Smoking and risk for amyotrophic lateral sclerosis: Analysis of the EPIC cohort
✍ Scribed by Valentina Gallo; H. Bas Bueno-De-Mesquita; Roel Vermeulen; Peter M. Andersen; Andreas Kyrozis; Jakob Linseisen; Rudolph Kaaks; Naomi E. Allen; Andrew W. Roddam; Hendriek C. Boshuizen; Petra H. Peeters; Domenico Palli; Amalia Mattiello; Sabina Sieri; Rosario Tumino; Juan-Manuel Jiménez-Martín; María José Tormo Díaz; Laudina Rodriguez Suarez; Antonia Trichopoulou; Antonio Agudo; Larraitz Arriola; Aurelio Barricante-Gurrea; Sheila Bingham; Kay-Tee Khaw; Jonas Manjer; Björn Lindkvist; Kim Overvad; Flemming W. Bach; Anne Tjønneland; Anja Olsen; Manuela M. Bergmann; Heiner Boeing; Francoise Clavel-Chapelon; Eiliv Lund; Göran Hallmans; Lefkos Middleton; Paolo Vineis; Elio Riboli
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 144 KB
- Volume
- 65
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The motor unit number estimate (MUNE), motor unit size, and conduction velocity (CV) of thenar surface-recorded motor unit action potentials (S-MUAPs) as collected by the automated F-wave technique were analyzed in 13 patients with amyotrophic lateral sclerosis (ALS) (aged 29-78 years, mean: 61) and
To examine the time-dependent e ects of exposure histories on disease we use sliding time windows as an exploratory alternative to the analysis of variables like time since last exposure and duration of exposure. The method ÿts a series of risk models which contain total cumulative exposure and an a
## Abstract ## Objective Venous thrombosis is a relatively frequent and serious complication in systemic lupus erythematosus (SLE) that has been associated with the presence of antiphospholipid antibodies (aPL). However, venous thrombotic events can also be seen in patients without aPL, and only a